On October 6, 2022, President Biden made a statement in which he asked the Secretary of Health and Human Services (HHS) and the Attorney General to review how marijuana is scheduled under federal law.

The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while maintaining federal controls.

On April 22, 2026, Acting Attorney General Todd Blanche issued a final order immediately placing both FDA-approved marijuana products ...

Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which includes drugs like ketamine, Tylenol with codeine and anabolic steroids.

For years, many in the medical and public health communities have anxiously awaited the long-overdue federal Controlled Substances Act reclassification of marijuana to characterize it more accurately.

A cannabis industry group calls President Trump's reclassification of state-licensed medical marijuana as a less-dangerous drug "the most significant federal advancement in cannabis policy" in decades ...

California officials are making additional reforms to help the state’s marijuana businesses take advantage of federal tax and ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related ...

Nevada is set to open the application window for licensing of marijuana consumption lounges across the state. The process will open for 10 business days between Oct. 14-27, the Nevada Cannabis ...